QFR® awarded Class I recommendation in 3 categories of the 2024 ESC guidelines for the management of Chronic Coronary Syndrome.

Medis’ Quantitative Flow Ratio (QFR®) has been awarded with a Class I recommendation in 3 distinct categories of the 2024 ESC guidelines for the management of patients suffering from chronic coronary syndrome (CCS). This recognition recommends QFR® as a physiology measurement technique next to, and at par with, the traditional wire-based methods. The guidelines also differentiate Medis QFR® from other Angiography-based FFR techniques, which have been called out with a lower IIb/C recommendation, in only one of the 3 categories.

Read More

GE HealthCare and Medis Medical Imaging Announce Collaboration focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease 

Today, GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Medis Medical Imaging, a leading cardiac imaging software company, announced their collaboration aimed at helping advance precision care in the diagnosis and treatment of coronary artery disease (CAD).

Read More

All good things come in 3.0: the release of Medis QFR® 3.0

We are excited to officially announce the launch of Medis QFR® 3.0, our latest solution designed to streamline your Cath lab workflow for physiology and morphology assessments of intermediate coronary lesions. This new version will bring innovative features, accessibility from anywhere within the hospital network, and a completely new look & feel.

Read More

Medis at CRT 2024: Review of the recent QFR Studies, principles of Medis QFR® and why we should use it by Yuhei Kobayashi, MD 

At CRT 2024, Yuhei Kobayashi, MD, will give an insightful session on the review of Medis QFR® and why you should use it. This session will take place on:

March 9, 9:41 AM – 9:49 AM ET in Lincoln

Read More

Join Medis today at the ECR 2024 in Vienna!

Read More
Excellent correlation and agreement between QFR and FFR demonstrated.

Excellent correlation and agreement between QFR and FFR demonstrated.

Cortés C. et al. published in Catheter Cardiovascular Interventions Journal an interesting meta-analysis and systematic review on QFR.

Read More
Diagnostic Performance of In‐Procedure Angiography‐Derived Quantitative Flow Reserve Compared to Pressure‐Derived Fractional Flow Reserve

Diagnostic Performance of In‐Procedure Angiography‐Derived Quantitative Flow Reserve Compared to Pressure‐Derived Fractional Flow Reserve

The FAVOR II E‐J and FAVOR II China studies, pioneering in‐procedure QFR assessment, revealed compelling results. FAVOR II E-J was a prospective, observational, investigator‐initiated study. Patients with stable angina pectoris were enrolled in 11 international centers.

Read More
QFR improves the diagnostic accuracy of coronary angiography

QFR improves the diagnostic accuracy of coronary angiography

Dr. Xu B. et al., performed a prospective, multicenter clinical trial to examine the diagnostic performance of QFR.

Read More
The use of two angiographic projections within Medis QFR® and the benefits over single-view projections.

The use of two angiographic projections within Medis QFR® and the benefits over single-view projections.

The Medis QFR® approach is based on the 3D reconstruction of a selected coronary segment from two X-ray angiographic views at least 25 degrees apart, and on the assessment of the flow velocity through the vessel following strict acquisition guidelines.

Read More
From research to release: additional normal values included in the release of Medis Suite MR

From research to release: additional normal values included in the release of Medis Suite MR

Last year a paper was published on normal values scanned on a 3T MR machine (doi: 10.1002/jmri.28903). In this study MRI reference ranges of left and right ventricular (LV and RV) morphology and function were established, based on a large multicenter cohort.

Read More